
On 29 May 2024, the Government introduced two pieces of regulation which restrict how trans children and young people under 18 years old can access some medications (GnRH analogues) which delay the effects of puberty as a result of a diagnosis of gender incongruence or gender dysphoria. These medicines consist of or contain buserelin, gonadorelin, goserelin, leuprorelin acetate, nafarelin or triptorelin. We will call these GnRH analogues throughout this information to prevent confusion with other medications. This legislation applies in England, Wales and Scotland. Following the Government’s announcement, NHS England wrote to the parents and guardians of all young people…